ChemChina given go-ahead for Syngenta deal in EU
Chinese agrochemical giant ChemChina has won European Union (EU) antitrust approval for its takeover of Swiss company Syngenta. The deal was made for $43 billion, and will result in a truly huge agricultural vehicle, able to access economies of scale previously unheard of, and compete in a tougher agricultural environment.
The ChemChina deal is part of a spate of M&A activity amongst the world’s biggest agricultural companies. Dow Chemical Co. is merging with DuPont Co., and Bayer AG is hoping to gain EU clearance for its purchase of Monsanto Co. In short, 6 of the biggest agricultural companies on the planet will reform into 3 titans, vastly altering the agribusiness landscape in the process.
Syngenta has had a strong year-to-date
SOURCE: Yahoo Finance
EU approval is, however, conditional. Regulators have called upon ChemChina to divest “a significant part” of its Adama unit’s pesticide business, as well as other related products. The EU’s statement read:
“In all product markets with problematic overlaps ChemChina will divest either Adama’s or Syngenta’s product. As a result, the commission has approved the transaction.”
U.S. antitrust authorities reached a similar conclusion the day before, and Chinese regulators are currently reviewing the deal. ChemChina and Syngenta expect to close the deal by the end of June, bringing us closer to a whole new world of agribusiness!
Dominion holds Syngenta in its Global Trends Managed Fund.
If you would you like to receive the Newsfeeds daily, please click here to sign up now!Help us make this Newsfeed better by rating this article. 1 star = Poor and 5 stars = Excellent
- Click here to print this story: Print
The views expressed in this article are those of the author at the date of publication and not necessarily those of Dominion Fund Management Limited. The content of this article is not intended as investment advice and will not be updated after publication. Images, video, quotations from literature and any such material which may be subject to copyright is reproduced in whole or in part in this article on the basis of Fair use as applied to news reporting and journalistic comment on events.